HR 8168 116th Congress House Health Blood and blood diseases Congressional oversight Disability and health-based discrimination Government information and archives HIV/AIDS Health information and medical records Health promotion and preventive care Infectious and parasitic diseases Sex, gender, sexual orientation discrimination Sexually transmitted diseases

Science in Blood Donation Act of 2020

Introduced: September 4, 2020 See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 4, 2020

Referred to the House Committee on Energy and Commerce.

Sep 4, 2020

Introduced in House

Plain-English summary Congressional Research Service

Science in Blood Donation Act of 2020

This bill requires the Food and Drug Administration (FDA) to revise its guidance on reducing the risk of transmitting by blood transfusion human immunodeficiency virus, hepatitis A, and hepatitis B.

Specifically, the FDA shall update its guidance to remove recommendations to not receive blood donations from a man who had sex with another man in the past three months. The FDA shall also remove recommendations to not receive blood donations from a woman who in the last three months had sex with such a man.

The FDA's updated guidance shall be based on an individual risk assessment of sexual behaviors that evaluate all donors equally without regard to sexual orientation or gender identity.

What's happening now September 4, 2020

Referred to the House Committee on Energy and Commerce.

Committees of jurisdiction 1